Table 1.
Frequency of the clinical and demographic characteristics of Lower (LGG) and High Grade Glioma (HGG) groups.
| LGG group (N 80) | HGG group (N. 65) | Significance (X2) | |||
|---|---|---|---|---|---|
| CLINICAL VARIABLES | % | N | % | N | |
| Histological Profile | |||||
| Astrocytoma | 30,0 | 24 | / | / | |
| Oligodendroglioma | 28,75 | 23 | / | / | |
| Gangoglioma | 17,5 | 14 | / | / | |
| Anaplastic Astrocitoma | / | / | 12,3 | 8 | |
| Anaplastic Oligodendroglioma | / | / | 18,5 | 12 | |
| Glioblastoma | / | / | 69,2 | 45 | |
| Other | 23,75 | 19 | / | / | |
| IDH | 0.001 | ||||
| Mutate | 73,8 | 59 | 33,8 | 22 | |
| Wildtype | 26,3 | 21 | 66,2 | 43 | |
| HEMISPHERIC LATERALITY | 0.335 | ||||
| Right | 53,8 | 43 | 33,8 | 22 | |
| Left | 46,3 | 37 | 66,2 | 43 | |
| LOBE AFFECTED | 0.107 | ||||
| Frontal | 51,2 | 41 | 27,7 | 18 | |
| Insular | 18,2 | 15 | 10,8 | 7 | |
| Temporal | 12,5 | 10 | 33,8 | 22 | |
| Parietal | 16,3 | 13 | 23,1 | 15 | |
| Other | 1,3 | 1 | 4,6 | 3 | |
| ADJUVANT THERAPY | 0 | ||||
| Chemotherapy | 57,5 | 46 | 98,5 | 64 | |
| Radiotherapy | 52,5 | 42 | 98,5 | 64 | |
| Gender | 0.33 | ||||
| Male | 57,5 | 46 | 64,6 | 42 | |
| Female | 42,5 | 34 | 35,4 | 23 | |
| Age | 0 | ||||
| Mean (SD) | 39,70 (11,3) | 51,2 (13,3) | |||
| Education | 0.975 | ||||
| Mean (SD) | 13,9 (3,01) | 13,7 (3,25) | |||
Clinical and demographics characteristics of Low Grade Glioma (LGG) and High Grade Glioma (HGG) groups. For each group and for each variables the percentage (%) total number (N) of subjects and X2 was reported.